Alpha Dna Investment Management LLC Biocryst Pharmaceuticals Inc Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 58,898 shares of BCRX stock, worth $465,294. This represents 0.17% of its overall portfolio holdings.
Number of Shares
58,898Holding current value
$465,294% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
171MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$158 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$93.7 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$71.8 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$69.9 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.47B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...